Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15345589 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Condition: Follicular Lymphoma
Intervention: Drug: BeEAM

Study has passed its completion date and status has not been verified in more than two years.